474 related articles for article (PubMed ID: 35948371)
1. Neurodegeneration in multiple sclerosis.
Mey GM; Mahajan KR; DeSilva TM
WIREs Mech Dis; 2023 Jan; 15(1):e1583. PubMed ID: 35948371
[TBL] [Abstract][Full Text] [Related]
2. Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications.
Simkins TJ; Duncan GJ; Bourdette D
Curr Neurol Neurosci Rep; 2021 Apr; 21(6):26. PubMed ID: 33835275
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
Ellwardt E; Zipp F
Exp Neurol; 2014 Dec; 262 Pt A():8-17. PubMed ID: 24530639
[TBL] [Abstract][Full Text] [Related]
4. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
5. Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.
Faissner S; Plemel JR; Gold R; Yong VW
Nat Rev Drug Discov; 2019 Dec; 18(12):905-922. PubMed ID: 31399729
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
Minagar A; Toledo EG; Alexander JS; Kelley RE
J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
[TBL] [Abstract][Full Text] [Related]
7. Remyelinating strategies: What can be learned from normal brain development.
Shelestak J; Irfan M; DeSilva TM
Curr Opin Pharmacol; 2022 Dec; 67():102290. PubMed ID: 36195009
[TBL] [Abstract][Full Text] [Related]
8. Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis.
Ziemssen T
J Neurol; 2005 Nov; 252 Suppl 5():v38-45. PubMed ID: 16254701
[TBL] [Abstract][Full Text] [Related]
9. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Brück W
J Neurol; 2005 Nov; 252 Suppl 5():v3-9. PubMed ID: 16254699
[TBL] [Abstract][Full Text] [Related]
10. [Neuroprotection in the treatment of multiple sclerosis].
Zipp F; Gold R
Nervenarzt; 2011 Aug; 82(8):973-7. PubMed ID: 21761185
[TBL] [Abstract][Full Text] [Related]
11. Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.
Bar-Or A; Rieckmann P; Traboulsee A; Yong VW
CNS Drugs; 2011 Sep; 25(9):783-99. PubMed ID: 21870889
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis - remyelination failure as a cause of disease progression.
Hagemeier K; Brück W; Kuhlmann T
Histol Histopathol; 2012 Mar; 27(3):277-87. PubMed ID: 22237705
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of Neurodegeneration in Multiple Sclerosis].
Eliseeva DD; Zakharova MN
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7. Vyp. 2):5-13. PubMed ID: 35912550
[TBL] [Abstract][Full Text] [Related]
14. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.
Wujek JR; Bjartmar C; Richer E; Ransohoff RM; Yu M; Tuohy VK; Trapp BD
J Neuropathol Exp Neurol; 2002 Jan; 61(1):23-32. PubMed ID: 11829341
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation.
Madsen PM; Pinto M; Patel S; McCarthy S; Gao H; Taherian M; Karmally S; Pereira CV; Dvoriantchikova G; Ivanov D; Tanaka KF; Moraes CT; Brambilla R
J Neurosci; 2017 Oct; 37(42):10185-10199. PubMed ID: 28931570
[TBL] [Abstract][Full Text] [Related]
16. Axonal loss in multiple sclerosis: causes and mechanisms.
Criste G; Trapp B; Dutta R
Handb Clin Neurol; 2014; 122():101-13. PubMed ID: 24507515
[TBL] [Abstract][Full Text] [Related]
17. Axonal pathology in multiple sclerosis: relationship to neurologic disability.
Trapp BD; Ransohoff R; Rudick R
Curr Opin Neurol; 1999 Jun; 12(3):295-302. PubMed ID: 10499174
[TBL] [Abstract][Full Text] [Related]
18. Axonal damage in central and peripheral nervous system inflammatory demyelinating diseases: common and divergent pathways of tissue damage.
Barnett MH; Mathey E; Kiernan MC; Pollard JD
Curr Opin Neurol; 2016 Jun; 29(3):213-21. PubMed ID: 27058223
[TBL] [Abstract][Full Text] [Related]
19. Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis.
Gharagozloo M; Mace JW; Calabresi PA
Front Mol Neurosci; 2022; 15():995477. PubMed ID: 36407761
[TBL] [Abstract][Full Text] [Related]
20. The good and the bad of neuroinflammation in multiple sclerosis.
Naegele M; Martin R
Handb Clin Neurol; 2014; 122():59-87. PubMed ID: 24507513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
